Peptide Report
MOTS-c Peptide Report
Catalog report for MOTS-c, generated from Peptide Stacks product data and linked to the matching PeptideReports protocol page when available.
Current Price$40.00 – $120.00 CAD
Common Uses
People commonly discuss MOTS-c for mitochondrial support, energy, endurance, metabolic health, and healthy-aging routines.
How It Works
MOTS-c is a mitochondrial-derived peptide. It is studied for effects on AMPK-related metabolic signaling, glucose handling, cellular stress responses, mitochondrial function, and exercise-like adaptation pathways.
Storage
Powder form: In lyophilized powder form, MOTS-c is generally kept sealed, dry, protected from direct light, and refrigerated unless the product label or certificate of analysis gives different handling instructions. Avoid leaving vials in hot rooms, vehicles, direct sunlight, or other temperature swings, because moisture, heat, and light are the main storage conditions people try to control before reconstitution.
Reconstituted: After reconstitution, MOTS-c should generally be treated as more sensitive: keep it refrigerated, minimize unnecessary handling, avoid shaking, and use clean handling practices each time the vial is accessed. Follow the product label, protocol page, and any pharmacy or lab guidance for beyond-use timing; if the solution changes color, becomes cloudy, develops particles, or the vial integrity is questionable, it should not be used.
Protocol
The full MOTS-c protocol is included below. The standalone protocol page remains available if you want to open it separately.
Open Standalone Protocol
Scope
Reconstitution examples, syringe conversion and community-reported usage patterns.
Available strengths: 10 MG and 40 MG
Preparation Examples
These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.
| Setup |
Diluent |
Concentration |
Unit conversion |
| 10 MG vial example |
Add 2.0 mL bacteriostatic water |
5 mg/mL |
Each U-100 unit = 0.05 mg |
| 40 MG vial example |
Add 2.0 mL bacteriostatic water |
20 mg/mL |
Each U-100 unit = 0.20 mg |
Syringe Conversion
| Reported amount |
10 MG setup |
40 MG setup |
| 1 mg |
20 units |
5 units |
| 2 mg |
40 units |
10 units |
| 3 mg |
60 units |
15 units |
| 5 mg |
100 units |
25 units |
Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.
Community-Reported Patterns
| Recurring report |
Frequency seen |
Context in reports |
| 2 mg |
Every other day or 3-5 days/week |
General metabolic or training use |
| 3 mg |
Before activity or 5 days/week |
Energy and endurance reports |
| 5 mg |
3-4 days/week |
Higher-dose cycle reports |
Observations
- Community reports span approximately 2-5 mg per administration; frequency varies substantially.
- Several contributors stressed recording active amount in mg rather than syringe units.
- Reported cycles commonly included breaks, but duration and break length were inconsistent.
Caveats
- Posts contained conflicting claims about stability after reconstitution; follow the dispensing pharmacy's storage and beyond-use directions.
- Reported experiences included changes in energy, exercise tolerance and resting heart rate, but these anecdotes do not establish causation.